Ben Tillotson, based in Kirkland, WA, US, is currently a Director Gene Delivery P and AD at Bristol Myers Squibb, bringing experience from previous roles at Bristol Myers Squibb, Juno Therapeutics, Inc. and Amgen. Ben Tillotson holds a 2007 - 2013 PhD in Chemical and Biological Engineering @ University of Wisconsin-Madison. With a robust skill set that includes Protein Chemistry, Protein Purification, Antibodies, Protein Expression, Biotechnology and more, Ben Tillotson contributes valuable insights to the industry. Ben Tillotson has 4 emails and 1 mobile phone number on RocketReach.